Ovarian stimulation in cancer patients

Fertility and Sterility

Volumn 99, Issue 6, 2013, Pages 1476-1484

  Cakmak, Hakan ^a   Rosen, Mitchell P ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cancer; fertility preservation; ovarian stimulation; random start

Indexed keywords

GONADORELIN AGONIST; GONADORELIN ANTAGONIST; GONADOTROPIN; LETROZOLE; LEUPRORELIN; LUTEINIZING HORMONE; RECOMBINANT FOLLITROPIN; TAMOXIFEN;

ARTICLE; BREAST CANCER; CANCER PATIENT; CANCER THERAPY; CHEMORADIOTHERAPY; CORPUS LUTEUM; CRYOPRESERVATION; DOUBLE STRANDED DNA BREAK; EMBRYO TRANSFER; ESTROGEN SYNTHESIS; EXCITATION AND STIMULATION; FEMALE SUBFERTILITY; FERTILIZATION IN VITRO; FOLLICULAR PHASE; HUMAN; LUTEAL PHASE; LUTEOLYSIS; MALNUTRITION; MENSTRUAL CYCLE; META ANALYSIS (TOPIC); MULTICENTER STUDY (TOPIC); NIDATION; OOCYTE; OOCYTE DEVELOPMENT; OOCYTE MATURATION; OOCYTE RETRIEVAL; OVARIAN RESERVE; OVARY; OVARY CANCER; OVARY HYPERSTIMULATION; OVARY STIMULATION; PREGNANCY; PREGNANCY RATE; PRIORITY JOURNAL; REPRODUCTIVE PROCEDURE;

EID: 84876979383     PISSN: 00150282     EISSN: 15565653     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2013.03.029     Document Type: Review

References (63)

1. American Cancer Society Cancer facts and figures 2012 2012 American Cancer Society Atlanta Available at: http://www.cancer.org/research/ cancerfactsfigures/cancerfactsfigures/cancer-facts-figures-2012 Accessed December 16, 2012
2. Howlader N, Noone AM, Krapcho M, Neyman N, Aminou R, Waldron W, et al. (eds.). SEER cancer statistics review, 1975-2009 (vintage 2009 populations). Bethesda, MD: National Cancer Institute. Available at: http://seer.cancer.gov/ csr/1975-2009-pops09/. Accessed December 16, 2012.
3. J.M. Letourneau, E.E. Ebbel, P.P. Katz, A. Katz, W.Z. Ai, and A.J. Chien Pretreatment fertility counseling and fertility preservation improve quality of life in reproductive age women with cancer Cancer 118 2012 1710 1717
4. J.M. Letourneau, M.E. Melisko, M.I. Cedars, and M.P. Rosen A changing perspective: improving access to fertility preservation Nat Rev Clin Oncol 8 2011 56 60
5. K.A. Rodriguez-Wallberg, and K. Oktay Options on fertility preservation in female cancer patients Cancer Treat Rev 38 2012 354 361
6. C.A. Sklar, A.C. Mertens, P. Mitby, J. Whitton, M. Stovall, and C. Kasper Premature menopause in survivors of childhood cancer: a report from the childhood cancer survivor study J Natl Cancer Inst 98 2006 890 896
7. T. Maltaris, R. Seufert, F. Fischl, M. Schaffrath, K. Pollow, and H. Koelbl The effect of cancer treatment on female fertility and strategies for preserving fertility Eur J Obstet Gynecol Reprod Biol 130 2007 148 155
8. J.M. Letourneau, E.E. Ebbel, P.P. Katz, K.H. Oktay, C.E. McCulloch, and W.Z. Ai Acute ovarian failure underestimates age-specific reproductive impairment for young women undergoing chemotherapy for cancer Cancer 118 2012 1933 1939
9. D. Meirow, and D. Nugent The effects of radiotherapy and chemotherapy on female reproduction Hum Reprod Update 7 2001 535 543
10. B.E. Hamilton, J.A. Martin, and S.J. Ventura Births: preliminary data for 2011 National vital statistics reports web release vol. 61, no. 5 2012 National Center for Health Statistics Hyattsville, MD
11. R.A. Anderson, and W.H. Wallace Fertility preservation in girls and young women Clin Endocrinol (Oxf) 75 2011 409 419
12. Practice Committee of the American Society for Reproductive Medicine Fertility preservation and reproduction in cancer patients Fertil Steril 83 2005 1622 1628
13. Practice Committee of the American Society for Reproductive Medicine Mature oocyte cryopreservation: a guideline Fertil Steril 99 2013 37 43
14. S. Lee, S. Ozkavukcu, E. Heytens, F. Moy, and K. Oktay Value of early referral to fertility preservation in young women with breast cancer J Clin Oncol 28 2010 4683 4686
15. J. Reddy, and K. Oktay Ovarian stimulation and fertility preservation with the use of aromatase inhibitors in women with breast cancer Fertil Steril 98 2012 1363 1369
16. S. Friedler, O. Koc, Y. Gidoni, A. Raziel, and R. Ron-El Ovarian response to stimulation for fertility preservation in women with malignant disease: a systematic review and meta-Analysis Fertil Steril 97 2012 125 133
17. A. Agarwal, and T.M. Said Implications of systemic malignancies on human fertility Reprod Biomed Online 9 2004 673 679
18. K. Oktay, J.Y. Kim, D. Barad, and S.N. Babayev Association of BRCA1 mutations with occult primary ovarian insufficiency: a possible explanation for the link between infertility and breast/ovarian cancer risks J Clin Oncol 28 2010 240 244
19. L. Pal, L. Leykin, J.L. Schifren, K.B. Isaacson, Y.C. Chang, and N. Nikruil Malignancy may adversely influence the quality and behaviour of oocytes Hum Reprod 13 1998 1837 1840
20. M. Das, F. Shehata, A. Moria, H. Holzer, W.Y. Son, and T. Tulandi Ovarian reserve, response to gonadotropins, and oocyte maturity in women with malignancy Fertil Steril 96 2011 122 125
21. J.M. Knopman, N. Noyes, S. Talebian, L.C. Krey, J.A. Grifo, and F. Licciardi Women with cancer undergoing ART for fertility preservation: a cohort study of their response to exogenous gonadotropins Fertil Steril 91 2009 1476 1478
22. A.D. Robertson, S.A. Missmer, and E.S. Ginsburg Embryo yield after in vitro fertilization in women undergoing embryo banking for fertility preservation before chemotherapy Fertil Steril 95 2011 588 591
23. S.C. Klock, J.X. Zhang, and R.R. Kazer Fertility preservation for female cancer patients: early clinical experience Fertil Steril 94 2010 149 155
24. D. Ford, D.F. Easton, and J. Peto Estimates of the gene frequency of BRCA1 and its contribution to breast and ovarian cancer incidence Am J Hum Genet 57 1995 1457 1462
25. W.T. Lin, M. Beattie, L. Chen, K. Oktay, S.L. Crawford, and E.B. Gold Comparison of age at natural menopause in BRCA1/2 mutation carriers with a non-clinic-based sample of women in northern California Cancer 2013 Jan 29 10.1002/cncr.27952 [Epub ahead of print]
26. B. Lawrenz, T. Fehm, M. von Wolff, M. Soekler, S. Huebner, and J. Henes Reduced pretreatment ovarian reserve in premenopausal female patients with Hodgkin lymphoma or non-Hodgkin-lymphoma - evaluation by using antimüllerian hormone and retrieved oocytes Fertil Steril 98 2012 141 144
27. E. Ebbel, A. Katz, C.N. Kao, M.I. Cedars, and M.P. Rosen Reproductive aged women with cancer have a lower antral follicle count than expected Fertil Steril 96 2011 S199 S200
28. J.L. Frattarelli, A.J. Levi, B.T. Miller, and J.H. Segars A prospective assessment of the predictive value of basal antral follicles in in vitro fertilization cycles Fertil Steril 80 2003 350 355
29. S. Lee, and K. Oktay Does higher starting dose of FSH stimulation with letrozole improve fertility preservation outcomes in women with breast cancer? Fertil Steril 98 2012 961 964.e1
30. E.B. Baart, E. Martini, M.J. Eijkemans, D. Van Opstal, N.G. Beckers, and A. Verhoeff Milder ovarian stimulation for in-vitro fertilization reduces aneuploidy in the human preimplantation embryo: a randomized controlled trial Hum Reprod 22 2007 980 988
31. J.F. McLaren, and G.W. Bates Fertility preservation in women of reproductive age with cancer Am J Obstet Gynecol 207 2012 455 462
32. R.A. Anderson, D. Kinniburgh, and D.T. Baird Preliminary experience of the use of a gonadotrophin-releasing hormone antagonist in ovulation induction/in-vitro fertilization prior to cancer treatment Hum Reprod 14 1999 2665 2668
33. P. Humaidan, L. Bungum, M. Bungum, F. Hald, I. Agerholm, and J. Blaabjerg Reproductive outcome using a GnRH antagonist (cetrorelix) for luteolysis and follicular synchronization in poor responder IVF/ICSI patients treated with a flexible GnRH antagonist protocol Reprod Biomed Online 11 2005 679 684
34. H. Cakmak, A.M. Zamah, A. Katz, M.I. Cedars, and M.P. Rosen Effective method for emergency fertility preservation: random-start controlled ovarian hyperstimulation Fertil Steril 98 2012 S170
35. M. Sonmezer, I. Turkcuoglu, U. Coskun, and K. Oktay Random-start controlled ovarian hyperstimulation for emergency fertility preservation in letrozole cycles Fertil Steril 95 2011 2125.e9 2125.e11
36. M. von Wolff, C.J. Thaler, T. Frambach, C. Zeeb, B. Lawrenz, and R.M. Popovici Ovarian stimulation to cryopreserve fertilized oocytes in cancer patients can be started in the luteal phase Fertil Steril 92 2009 1360 1365
37. A.R. Baerwald, G.P. Adams, and R.A. Pierson Characterization of ovarian follicular wave dynamics in women Biol Reprod 69 2003 1023 1031
38. K.A. Rodriguez-Wallberg, and K. Oktay Fertility preservation in women with breast cancer Clin Obstet Gynecol 53 2010 753 762
39. Early Breast Cancer Trialists' Collaborative Group Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. 133 randomised trials involving 31,000 recurrences and 24,000 deaths among 75,000 women Lancet 339 1992 71 85
40. K. Oktay, E. Buyuk, O. Davis, I. Yermakova, L. Veeck, and Z. Rosenwaks Fertility preservation in breast cancer patients: IVF and embryo cryopreservation after ovarian stimulation with tamoxifen Hum Reprod 18 2003 90 95
41. K. Oktay, E. Buyuk, N. Libertella, M. Akar, and Z. Rosenwaks Fertility preservation in breast cancer patients: a prospective controlled comparison of ovarian stimulation with tamoxifen and letrozole for embryo cryopreservation J Clin Oncol 23 2005 4347 4353
42. P.A. Cole, and C.H. Robinson Mechanism and inhibition of cytochrome P-450 aromatase J Med Chem 33 1990 2933 2942
43. I.E. Smith, and M. Dowsett Aromatase inhibitors in breast cancer N Engl J Med 348 2003 2431 2442
44. E.P. Winer, C. Hudis, H.J. Burstein, R.T. Chlebowski, J.N. Ingle, and S.B. Edge American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for women with hormone receptor-positive breast cancer: status report 2002 J Clin Oncol 20 2002 3317 3327
45. M.F. Mitwally, and R.F. Casper Use of an aromatase inhibitor for induction of ovulation in patients with an inadequate response to clomiphene citrate Fertil Steril 75 2001 305 309
46. J. Testart, R. Frydman, K. Nahoul, J. Grenier, M.C. Feinstein, and M. Roger Steroids and gonadotropins during the last pre-ovulatory phase of the menstrual cycle. Time relationships between plasma hormones levels and luteinizing hormone surge onset J Steroid Biochem 17 1982 675 682
47. K. Oktay, A. Hourvitz, G. Sahin, O. Oktem, B. Safro, and A. Cil Letrozole reduces estrogen and gonadotropin exposure in women with breast cancer undergoing ovarian stimulation before chemotherapy J Clin Endocrinol Metab 91 2006 3885 3890
48. L.N. Johnson, K.E. Dillon, M.D. Sammel, B.L. Efymow, M.A. Mainigi, and A. Dokras Response to ovarian stimulation in patients facing gonadotoxic therapy Reprod Biomed Online 2013 Jan 19 10.1016/j.rbmo.2013.01.003 [Epub ahead of print]
49. A.A. Azim, M. Costantini-Ferrando, and K. Oktay Safety of fertility preservation by ovarian stimulation with letrozole and gonadotropins in patients with breast cancer: a prospective controlled study J Clin Oncol 26 2008 2630 2635
50. A. Azim, and K. Oktay Letrozole for ovulation induction and fertility preservation by embryo cryopreservation in young women with endometrial carcinoma Fertil Steril 88 2007 657 664
51. K.O. Klein, L.M. Demers, S.J. Santner, J. Baron, G.B. Cutler Jr., and R.J. Santen Use of ultrasensitive recombinant cell bioassay to measure estrogen levels in women with breast cancer receiving the aromatase inhibitor, letrozole J Clin Endocrinol Metab 80 1995 2658 2660
52. A.A. Azim, M. Costantini-Ferrando, K. Lostritto, and K. Oktay Relative potencies of anastrozole and letrozole to suppress estradiol in breast cancer patients undergoing ovarian stimulation before in vitro fertilization J Clin Endocrinol Metab 92 2007 2197 2200
53. A. Delvigne, and S. Rozenberg Epidemiology and prevention of ovarian hyperstimulation syndrome (OHSS): a review Hum Reprod Update 8 2002 559 577
54. P. Humaidan, S. Kol, and E.G. Papanikolaou GnRH agonist for triggering of final oocyte maturation: time for a change of practice? Hum Reprod Update 17 2011 510 524
55. L. Engmann, A. DiLuigi, D. Schmidt, J. Nulsen, D. Maier, and C. Benadiva The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: a prospective randomized controlled study Fertil Steril 89 2008 84 91
56. K. Oktay, I. Turkcuoglu, and K.A. Rodriguez-Wallberg GnRH agonist trigger for women with breast cancer undergoing fertility preservation by aromatase inhibitor/FSH stimulation Reprod Biomed Online 20 2010 783 788
57. C.A. McArdle, J. Franklin, L. Green, and J.N. Hislop Signalling, cycling and desensitisation of gonadotrophin-releasing hormone receptors J Endocrinol 173 2002 1 11
58. J. Blankstein, J. Shalev, T. Saadon, E.E. Kukia, J. Rabinovici, and C. Pariente Ovarian hyperstimulation syndrome: prediction by number and size of preovulatory ovarian follicles Fertil Steril 47 1987 597 602
59. E.G. Papanikolaou, C. Pozzobon, E.M. Kolibianakis, M. Camus, H. Tournaye, and H.M. Fatemi Incidence and prediction of ovarian hyperstimulation syndrome in women undergoing gonadotropin-releasing hormone antagonist in vitro fertilization cycles Fertil Steril 85 2006 112 120
60. H. Cakmak, V.Y. Fujimoto, A.M. Zamah, M.P. Rosen, N.D. Tran, and M.I. Cedars Metaphase II (MII) oocytes obtained at different time points in the same in vitro fertilization cycle J Assist Reprod Genet 29 2012 1203 1205
61. M.H. Aurousseau, M.M. Samama, A. Belhassen, F. Herve, and J.N. Hugues Risk of thromboembolism in relation to an in-vitro fertilization programme: three case reports Hum Reprod 10 1995 94 97
62. Y. Yinon, R. Pauzner, M. Dulitzky, S.E. Elizur, J. Dor, and A. Shulman Safety of IVF under anticoagulant therapy in patients at risk for thrombo-embolic events Reprod Biomed Online 12 2006 354 358
63. A.M. Zamah, M.J. Mauro, B.J. Druker, K. Oktay, M.J. Egorin, and M.I. Cedars Will imatinib compromise reproductive capacity? Oncologist 16 2011 1422 1427